Chenyang Li Selected Research

Chenyang Li Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 09/2018
7	Infections 01/2022 - 01/2011
7	Inflammation (Inflammations) 10/2021 - 05/2012
5	Hypothyroidism 04/2015 - 06/2006
4	Breast Neoplasms (Breast Cancer) 07/2022 - 09/2018
4	Melanoma (Melanoma, Malignant) 03/2021 - 01/2019
4	Virus Diseases (Viral Diseases) 01/2021 - 04/2015
3	Rheumatoid Arthritis 01/2022 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
3	Carcinogenesis 01/2021 - 05/2020
3	Respiratory Syncytial Virus Infections 01/2021 - 04/2015
3	Postpartum Thyroiditis (Thyroiditis, Postpartum) 09/2015 - 01/2010
3	Thyroid Diseases (Thyroid Disease) 09/2015 - 06/2006
2	Colitis 08/2021 - 05/2012
2	Osteosarcoma (Osteogenic Sarcoma) 06/2021 - 01/2017
2	Edema (Dropsy) 01/2018 - 01/2013
2	Body Weight (Weight, Body) 07/2016 - 05/2012
2	Vitamin D Deficiency 09/2015 - 01/2014
1	Experimental Arthritis 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Synovitis 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Eczema 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Narcolepsy 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Endotoxemia 10/2021
1	Birth Weight (Birth Weights) 09/2021
1	Dyslipidemias (Dyslipidemia) 09/2021
1	Neoplasm Metastasis (Metastasis) 06/2021
1	Diarrhea 04/2021
1	Atherosclerosis 02/2021
1	Sleepiness 01/2021
1	Hemolysis 01/2021
1	Stroke (Strokes) 01/2021
1	Postpartum Depression (Post-Natal Depression) 11/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2012
5	IodineIBA 11/2020 - 06/2006
4	Long Noncoding RNAIBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 01/2019
3	SaponinsIBA 01/2022 - 01/2013
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
3	LipidsIBA 09/2021 - 05/2020
3	Messenger RNA (mRNA)IBA 08/2021 - 05/2012
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2020
2	AntioxidantsIBA 01/2022 - 01/2013
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2013
2	InflammasomesIBA 10/2021 - 08/2021
2	LeptinIBA 09/2021 - 11/2014
2	CaspasesIBA 03/2021 - 01/2019
2	SesquiterpenesIBA 03/2021 - 01/2019
2	LactonesIBA 03/2021 - 01/2019
2	anthecotulideIBA 03/2021 - 01/2019
2	InterferonsIBA 11/2020 - 05/2012
2	Biological ProductsIBA 11/2020 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018 - 05/2012
2	CytokinesIBA 07/2016 - 05/2012
2	EpitopesIBA 10/2015 - 11/2013
2	25-hydroxyvitamin DIBA 09/2015 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2015 - 11/2013
2	Iodide Peroxidase (Deiodinase)IBA 01/2015 - 01/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2022
1	Estrogen ReceptorsIBA 07/2022
1	CollagenIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	4-nitrophenethyl bromide (NPB)IBA 01/2022
1	TabletsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	chrysinIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022
1	Phenobarbital (Luminal)FDA Link 12/2021
1	Hormones (Hormone)IBA 12/2021
1	human ERBB2 proteinIBA 12/2021
1	SR9009IBA 10/2021
1	EndotoxinsIBA 10/2021
1	Adenosine Triphosphatases (ATPase)IBA 08/2021
1	Taurine FDA Link 06/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Alkaline PhosphataseIBA 04/2021
1	ZincIBA 04/2021
1	Zinc Oxide FDA Link 04/2021
1	ZeolitesIBA 04/2021
1	NF-kappa B (NF-kB)IBA 03/2021
1	CholesterolIBA 02/2021
1	Glycerophospholipids (Phosphoglycerides)IBA 02/2021
1	rhodiolosideIBA 02/2021
1	Apolipoproteins E (ApoE)IBA 02/2021
1	Beclin-1IBA 01/2021
1	KetonesIBA 01/2021
1	farnesyl pyrophosphate (farnesyl diphosphate)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	VitaminsIBA 11/2020
1	Histone Deacetylase InhibitorsIBA 11/2020

Therapy/Procedure

6	Therapeutics 11/2020 - 02/2019
1	Aftercare (After-Treatment) 01/2022
1	Complementary Therapies (Alternative Medicine) 02/2021